Does pharmacogenomics provide an ethical challenge to the utilisation of cost-effectiveness analysis by public health systems?
Creator
La Caze, Adam
Bibliographic Citation
Pharmacoeconomics 2005; 23(5): 445-447
Collections
Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
Pharmacogenomics and the evolution of healthcare: is it time for cost-effectiveness analysis at the individual level?
Bala, Mohan V.; Zarkin, Gary A. (2004) -
The role of cost-effectiveness analysis in the era of pharmacogenomics
Flowers, Christopher R.; Veenstra, David (2004) -
Cost-Effectiveness Analysis: Can We Reduce Variability in Costing Methods?
Adam, Taghreed; Koopmanschap, Marc A. (2003-03)